Wed, March 13, 2024
Tue, March 12, 2024
Mon, March 11, 2024
Fri, March 8, 2024

Josh Schimmer Maintained (BBIO) at Buy with Increased Target to $60 on, Mar 11th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-60-on-mar-11th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Josh Schimmer of Cantor Fitzgerald, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $50 to $60 on, Mar 11th, 2024.

Josh has made no other calls on BBIO in the last 4 months.



There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 1 agrees with Josh's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $37 on, Wednesday, January 31st, 2024


These are the ratings of the 3 analyists that currently disagree with Josh


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $53 on, Tuesday, March 5th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $47 on, Monday, March 4th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $46 on, Friday, February 23rd, 2024

Publication Contributing Sources